{"id":796797,"date":"2024-12-23T09:23:03","date_gmt":"2024-12-23T14:23:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/"},"modified":"2024-12-23T09:23:03","modified_gmt":"2024-12-23T14:23:03","slug":"sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/","title":{"rendered":"Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>PRINCETON, NJ, Dec.  23, 2024  (GLOBE NEWSWIRE) &#8212; <\/strong>Sonnet BioTherapeutics Holdings, Inc. (the \u201cCompany\u201d or \u201cSonnet\u201d) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced the next CEO Corner segment has been published on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5lntGgVg4sqMkYLi3lXMT4p7EMub73H3hi4HWTqME_K2dX9nphtJZzsebeFWcqMTaEFXRtxceIpiduTi9PQkFsYbGBuomtg-ikfU6aoWyew6EIH-OYGMm30ZuyOiejSM\" rel=\"nofollow\" target=\"_blank\"><u>Company\u2019s website<\/u><\/a>.<\/p>\n<p align=\"justify\">As part of the CEO Corner segment, Pankaj Mohan, Ph.D., Founder and Chief Executive Officer of Sonnet, highlighted the Company\u2019s key accomplishments for calendar year 2024 and the targeted value-driving milestones in calendar year 2025.<\/p>\n<p align=\"justify\">The CEO Corner is now accessible on the Company\u2019s website <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CIXRWZ2kW-UF6H02qRKKG1dwvg-nLY1cTJ3oXdAeCY-Y31a48ZpMRb11eF2AldvWb1jM-30pM0IYHKauIjGb6oKw4y5IBf97WbSJNbeVnD8=\" rel=\"nofollow\" target=\"_blank\"><u>here<\/u><\/a>. Segments on the CEO Corner platform will be accessible on the Company\u2019s website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zZ0m6mg1-cD5zwYzHx4MMIvTCmsY8_-c8_FtIYcLtnsDcFKlt_UVnP-m-J29Yk9d7RzTTCCNP7Joh02KzCA3eJBqXGMNQuMGyaNlJIa39J4=\" rel=\"nofollow\" target=\"_blank\"><u>www.sonnetbio.com<\/u><\/a>) for 90 days.<\/p>\n<p>\n        <strong>About Sonnet BioTherapeutics Holdings, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action. Known as F<sub>H<\/sub>AB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and &#8220;hitch-hikes&#8221; on human serum albumin (HSA) for transport to target tissues. Sonnet&#8217;s F<sub>H<\/sub>AB was designed to specifically target tumor and lymphatic tissue, with an improved therapeutic window for optimizing the safety and efficacy of immune modulating biologic drugs. F<sub>H<\/sub>AB is the foundation of a modular, plug-and-play construct for potentiating a range of large molecule therapeutic classes, including cytokines, peptides, antibodies, and vaccines.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>JTC Team, LLC<br \/>Jenene Thomas <br \/>908.824.0775<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5qGFB5Dq-Gg2ZqNY4Vv47yVwGWlngvTI4xS8LYZbaRxdSJWbmDHW2Enpwee2HyR4AGalQ1ftwwTXDTlAMP5x2A==\" rel=\"nofollow\" target=\"_blank\"><u>SONN@jtcir.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzE4MSM2NjY4ODIxIzUwMDEyNzk5Nw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTNlODYyMDUtMTAxZi00NDg0LWIzZTItNGNlNTE1OGRiYzc2LTUwMDEyNzk5Nw==\/tiny\/Sonnet-BioTherapeutics-Holding.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PRINCETON, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) &#8212; Sonnet BioTherapeutics Holdings, Inc. (the \u201cCompany\u201d or \u201cSonnet\u201d) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced the next CEO Corner segment has been published on the Company\u2019s website. As part of the CEO Corner segment, Pankaj Mohan, Ph.D., Founder and Chief Executive Officer of Sonnet, highlighted the Company\u2019s key accomplishments for calendar year 2024 and the targeted value-driving milestones in calendar year 2025. The CEO Corner is now accessible on the Company\u2019s website here. Segments on the CEO Corner platform will be accessible on the Company\u2019s website (www.sonnetbio.com) for 90 days. About Sonnet BioTherapeutics Holdings, Inc. Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-796797","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) &#8212; Sonnet BioTherapeutics Holdings, Inc. (the \u201cCompany\u201d or \u201cSonnet\u201d) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced the next CEO Corner segment has been published on the Company\u2019s website. As part of the CEO Corner segment, Pankaj Mohan, Ph.D., Founder and Chief Executive Officer of Sonnet, highlighted the Company\u2019s key accomplishments for calendar year 2024 and the targeted value-driving milestones in calendar year 2025. The CEO Corner is now accessible on the Company\u2019s website here. Segments on the CEO Corner platform will be accessible on the Company\u2019s website (www.sonnetbio.com) for 90 days. About Sonnet BioTherapeutics Holdings, Inc. Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating &hellip; Continue reading &quot;Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-23T14:23:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzE4MSM2NjY4ODIxIzUwMDEyNzk5Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment\",\"datePublished\":\"2024-12-23T14:23:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\\\/\"},\"wordCount\":233,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMzE4MSM2NjY4ODIxIzUwMDEyNzk5Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\\\/\",\"name\":\"Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMzE4MSM2NjY4ODIxIzUwMDEyNzk5Nw==\",\"datePublished\":\"2024-12-23T14:23:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMzE4MSM2NjY4ODIxIzUwMDEyNzk5Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMzE4MSM2NjY4ODIxIzUwMDEyNzk5Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/","og_locale":"en_US","og_type":"article","og_title":"Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment - Market Newsdesk","og_description":"PRINCETON, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) &#8212; Sonnet BioTherapeutics Holdings, Inc. (the \u201cCompany\u201d or \u201cSonnet\u201d) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced the next CEO Corner segment has been published on the Company\u2019s website. As part of the CEO Corner segment, Pankaj Mohan, Ph.D., Founder and Chief Executive Officer of Sonnet, highlighted the Company\u2019s key accomplishments for calendar year 2024 and the targeted value-driving milestones in calendar year 2025. The CEO Corner is now accessible on the Company\u2019s website here. Segments on the CEO Corner platform will be accessible on the Company\u2019s website (www.sonnetbio.com) for 90 days. About Sonnet BioTherapeutics Holdings, Inc. Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating &hellip; Continue reading \"Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-23T14:23:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzE4MSM2NjY4ODIxIzUwMDEyNzk5Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment","datePublished":"2024-12-23T14:23:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/"},"wordCount":233,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzE4MSM2NjY4ODIxIzUwMDEyNzk5Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/","name":"Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzE4MSM2NjY4ODIxIzUwMDEyNzk5Nw==","datePublished":"2024-12-23T14:23:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzE4MSM2NjY4ODIxIzUwMDEyNzk5Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzE4MSM2NjY4ODIxIzUwMDEyNzk5Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sonnet-biotherapeutics-announces-release-of-the-next-ceo-corner-segment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/796797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=796797"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/796797\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=796797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=796797"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=796797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}